|
ZNF397OS expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.093200E-01 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
8.465400E-01 |
| Normal-vs-Stage2 |
8.898400E-01 |
| Normal-vs-Stage3 |
2.773200E-01 |
| Normal-vs-Stage4 |
2.558200E-02 |
| Stage1-vs-Stage2 |
7.987600E-01 |
| Stage1-vs-Stage3 |
2.129400E-01 |
| Stage1-vs-Stage4 |
2.594100E-02 |
| Stage2-vs-Stage3 |
5.570200E-01 |
| Stage2-vs-Stage4 |
1.617350E-01 |
| Stage3-vs-Stage4 |
3.474000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.125400E-01 |
| Normal-vs-AfricanAmerican |
8.727800E-01 |
| Normal-vs-Asian |
4.398600E-01 |
| Caucasian-vs-AfricanAmerican |
4.930600E-01 |
| Caucasian-vs-Asian |
3.233400E-01 |
| AfricanAmerican-vs-Asian |
4.780200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
9.543600E-02 |
| Normal-vs-Female |
4.146400E-01 |
| Male-vs-Female |
2.271500E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
9.897000E-01 |
| Normal-vs-Age(41-60Yrs) |
4.831200E-01 |
| Normal-vs-Age(61-80Yrs) |
3.614500E-02 |
| Normal-vs-Age(81-100Yrs) |
4.646200E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.829200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.679800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.980400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
9.122300E-03 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.606600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.808600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
1.062980E-01 |
| Normal-vs-Grade 2 |
2.591800E-01 |
| Normal-vs-Grade 3 |
1.549410E-01 |
| Normal-vs-Grade 4 |
1.977660E-04 |
| Grade 1-vs-Grade 2 |
3.016800E-01 |
| Grade 1-vs-Grade 3 |
3.876400E-02 |
| Grade 1-vs-Grade 4 |
1.377730E-03 |
| Grade 2-vs-Grade 3 |
1.855700E-02 |
| Grade 2-vs-Grade 4 |
5.77459999999697E-05 |
| Grade 3-vs-Grade 4 |
7.403100E-03 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
6.850400E-02 |
| Normal-vs-ccB subtype |
2.350500E-02 |
| ccA subtype-vs-ccB subtype |
2.802400E-04 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
7.466800E-01 |
| Normal-vs-N1 |
1.902580E-01 |
| N0-vs-N1 |
2.821000E-01 |
|
|
